Insider Transactions Reported by 34 Insiders of Monte Rosa Therapeutics, Inc.

Symbol
GLUE on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Monte Rosa Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley J. Bolzon PhD Director, 10%+ Owner $169,044,007 28 Jun 2021
New Enterprise Associates 17, L.P. 10%+ Owner $146,153,662 28 Jun 2021
Liza Landsman 10%+ Owner $146,153,662 28 Jun 2021
Carmen Chang 10%+ Owner $146,153,662 28 Jun 2021
Anthony A. Florence Jr. 10%+ Owner $146,153,662 28 Jun 2021
Mathers Edward T. 10%+ Owner $146,153,662 28 Jun 2021
Paul Edward Walker 10%+ Owner $146,153,662 28 Jun 2021
Mohamad Makhzoumi 10%+ Owner $146,153,662 28 Jun 2021
JOSHUA MAKOWER 10%+ Owner $146,153,662 28 Jun 2021
Peter W. Sonsini 10%+ Owner $146,153,662 28 Jun 2021
FOREST BASKETT 10%+ Owner $146,153,662 28 Jun 2021
Rick Yang 10%+ Owner $146,153,662 28 Jun 2021
Scott D. Sandell 10%+ Owner $146,153,662 28 Jun 2021
Cormorant Asset Management, LP Former 10% Owner $60,841,800 28 Jun 2021
Versant Venture Capital VI, L.P. 10%+ Owner $53,192,865 28 Oct 2024
Markus Warmuth President & CEO, Director $10,996,038 -$380,095 -3.3% 02 Mar 2026
Filip Janku Chief Medical Officer $1,283,643 -$227,022 -15% 23 Feb 2026
Sharon Townson Chief Scientific Officer $1,029,208 -$47,861 -4.4% 02 Jan 2026
Jennifer Champoux Chief Operating Officer $946,168 -$39,882 -4% 02 Jan 2026
Philip Nickson Chief Business & Legal Officer $923,018 -$47,861 -4.9% 02 Jan 2026
Edmund Dunn Principal Accounting Officer $405,069 -$492,319 -55% 04 Mar 2026
Owen B. Wallace Chief Scientific Officer $100,054 02 Jan 2024
Chandra P. Leo Director $58,383 +$58,383 24 Mar 2025
ANDREW N. SCHIFF Director 13 Jun 2025
Jan Skvarka Director 13 Jun 2025
Alexander Mayweg Director 14 Jun 2023
Kimberly Blackwell Director 13 Jun 2025
Anthony M. Manning Director 13 Jun 2025
John C. Castle Chief Data Scientist 03 Jan 2023
Eric A. Hughes Director 13 Jun 2025
Ali Behbahani Director, 10%+ Owner 13 Jun 2025
Jullian G. Jones Chief Business Officer 02 Jan 2024
Christine Siu Director 13 Jun 2025
Ajim Tamboli Chief Financial Officer 03 Jan 2023

Recent Insider Transactions by Companies or Individuals for Monte Rosa Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Edmund Dunn GLUE Common Stock Sale -0.61% $2,496 $17.96 -139 22,554 04 Mar 2026 Direct
Markus Warmuth GLUE Common Stock Sale -0.88% $97,974 $17.92 -5,466 613,471 02 Mar 2026 Direct
Edmund Dunn GLUE Common Stock Sale -2.31% $9,380 $17.50 -536 22,693 02 Mar 2026 Direct
Edmund Dunn GLUE Common Stock Options Exercise 2.36% 536 23,229 02 Mar 2026 Direct
Edmund Dunn GLUE Stock Option (Right to Buy) Options Exercise -100% -536 0 02 Mar 2026 Direct
Edmund Dunn GLUE Common Stock Sale -52.6% $455,506 $18.10 -25,164 22,693 27 Feb 2026 Direct
Edmund Dunn GLUE Common Stock Options Exercise 110.9% 25,164 47,857 27 Feb 2026 Direct
Edmund Dunn GLUE Stock Option (Right to Buy) Options Exercise -97.9% -25,164 536 27 Feb 2026 Direct
Filip Janku GLUE Common Stock Sale -12.2% $179,161 $19.50 -9,189 65,837 23 Feb 2026 Direct
Markus Warmuth GLUE Common Stock Sale -0.88% $128,373 $23.49 -5,466 618,937 07 Jan 2026 Direct
Philip Nickson GLUE Common Stock Sale -4.93% $47,861 $15.17 -3,155 60,845 05 Jan 2026 Direct
Jennifer Champoux GLUE Common Stock Sale -4.04% $39,882 $15.17 -2,629 62,371 05 Jan 2026 Direct
Edmund Dunn GLUE Common Stock Sale -4.38% $15,762 $15.17 -1,039 22,693 05 Jan 2026 Direct
Markus Warmuth GLUE Common Stock Sale -1.6% $153,748 $15.17 -10,135 624,403 05 Jan 2026 Direct
Filip Janku GLUE Common Stock Sale -4.04% $47,861 $15.17 -3,155 75,026 05 Jan 2026 Direct
Sharon Townson GLUE Common Stock Sale -4.44% $47,861 $15.17 -3,155 67,845 05 Jan 2026 Direct
Philip Nickson GLUE Common Stock Award 77.8% 28,000 64,000 02 Jan 2026 Direct
Philip Nickson GLUE Stock Option (Right to Buy) Award 126,000 126,000 02 Jan 2026 Direct
Jennifer Champoux GLUE Common Stock Award 116.7% 35,000 65,000 02 Jan 2026 Direct
Jennifer Champoux GLUE Stock Option (Right to Buy) Award 158,000 158,000 02 Jan 2026 Direct
Markus Warmuth GLUE Common Stock Award 16.5% 90,000 634,538 02 Jan 2026 Direct
Markus Warmuth GLUE Stock Option (Right to Buy) Award 406,000 406,000 02 Jan 2026 Direct
Filip Janku GLUE Common Stock Award 65.7% 31,000 78,181 02 Jan 2026 Direct
Filip Janku GLUE Stock Option (Right to Buy) Award 139,000 139,000 02 Jan 2026 Direct
Sharon Townson GLUE Common Stock Award 97.2% 35,000 71,000 02 Jan 2026 Direct
Sharon Townson GLUE Stock Option (Right to Buy) Award 158,000 158,000 02 Jan 2026 Direct
Ali Behbahani GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Eric A. Hughes GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Anthony M. Manning GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Kimberly Blackwell GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Christine Siu GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Jan Skvarka GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
ANDREW N. SCHIFF GLUE Stock Option (Right to Buy) Award 30,700 30,700 13 Jun 2025 Direct
Edmund Dunn GLUE Common Stock Sale -7.99% $9,174 $4.45 -2,062 23,732 03 Jun 2025 Direct
Chandra P. Leo GLUE Common Stock Purchase $58,383 $5.84 10,000 10,000 24 Mar 2025 Direct
Philip Nickson GLUE Common Stock Award 36,000 36,000 02 Jan 2025 Direct
Philip Nickson GLUE Stock Option (Right to Buy) Award 161,000 161,000 02 Jan 2025 Direct
Edmund Dunn GLUE Common Stock Award 85% 11,850 25,794 02 Jan 2025 Direct
Edmund Dunn GLUE Stock Option (Right to Buy) Award 53,400 53,400 02 Jan 2025 Direct
Filip Janku GLUE Common Stock Award 391.8% 36,000 45,189 02 Jan 2025 Direct
Filip Janku GLUE Stock Option (Right to Buy) Award 161,000 161,000 02 Jan 2025 Direct
Jennifer Champoux GLUE Common Stock Award 30,000 30,000 02 Jan 2025 Direct
Jennifer Champoux GLUE Stock Option (Right to Buy) Award 135,000 135,000 02 Jan 2025 Direct
Markus Warmuth GLUE Common Stock Award 30.7% 128,000 544,538 02 Jan 2025 Direct
Markus Warmuth GLUE Stock Option (Right to Buy) Award 575,000 575,000 02 Jan 2025 Direct
Sharon Townson GLUE Common Stock Award 36,000 36,000 02 Jan 2025 Direct
Sharon Townson GLUE Stock Option (Right to Buy) Award 161,000 161,000 02 Jan 2025 Direct
Eric A. Hughes GLUE Stock Option (Right to Buy) Award 44,200 44,200 11 Dec 2024 Direct
Versant Venture Capital VI, L.P. GLUE Common Stock Sale -4.14% $621,801 $9.16 -67,905 1,573,453 29 Oct 2024 See Footnote
Versant Venture Capital VI, L.P. GLUE Common Stock Other -100% -415,535 0 28 Oct 2024 See Footnote
* An asterisk sign (*) next to the price indicates that the price is likely invalid.